Aa
Aa
A
A
A
Close
572651 tn?1530999357

Lemtrada update

If you are following the approval of Genzyme Sanofi's re-purposing of their chemo drug to be used for MS as Lemtrada, you will be interested to read it appears the FDA had brought that plan to a screeching halt .

http://www.businessweek.com/news/2013-11-08/sanofi-multiple-sclerosis-drug-may-be-too-risky-fda-staff-says
5 Responses
Sort by: Helpful Oldest Newest
572651 tn?1530999357
Hi, Chris.  Thanks for sharing your blog that helps us understand the financial upside of Lemtrada being approved.  I have also blogged about this company and this drug, neither of which I like much, but bottom line is people with aggressive forms of MS should be given this drug as an option.

The latest this week is the drug's lead  investigators are planning to file their own appeal of the decision.  You might find their perspective interesting that if patients here in the US can't get this treatment, they may take the same route as CCSVI and become medical tourists and travel to Europe or Canada for treatment.

Now there's a bull tip  - medical tourism is a booming trend.  

You don't say in your blog - do you have a personal connection with MS as well?
best, Laura
Helpful - 0
Avatar universal
Lemtrada Works And MS Patients Want A Choice:  http://seekingalpha.com/instablog/957061-chris-demuth-jr/2582421-lemtrada-works-and-ms-patients-want-a-choice
Helpful - 0
738075 tn?1330575844
Yeah, the guys over at Barts and the London were talking about it, too.  A couple of interesting comments, too.

http://multiple-sclerosis-research.blogspot.com/2013/11/is-alemtuzumab-too-risky.html

I'm pretty sure I don't want to try it.
1) Tysabri is working well, and I'm JCV negative.
2) Lemtrada just sounds too risky (I know folks have said that about Tysabri, lol)
Helpful - 0
Avatar universal
that's strange because my neuro told me it was "coming out" the end of the year and he wants to put me on it.  One of our forum members was in the trials.
Helpful - 0
5112396 tn?1378017983
Yikes. That article doesn't make it sound like the FDA is out of line on this at all. In the risk-benefit ratio, it would seem this one doesn't stack up.

I'm a bit confused by the phrasing 'FDA staff says' though, versus 'The FDA states'. Is this just an unnamed source situation?
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1671273328
Australia
5265383 tn?1669040108
ON
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease